Thailand-Malaysia Regulatory Reliance Pilot: What the ASEAN Cascade Could Mean for You

Thailand and Malaysia have been piloting a bilateral regulatory reliance arrangement for medical devices that, if formalized and expanded, could significantly change the market entry calculus for manufacturers targeting multiple ASEAN countries simultaneously. The direction of the pilot is specific: devices approved by Malaysia's Medical Device Authority (MDA) can receive expedited review from the Thai FDA, with Thailand relying on Malaysia's assessment rather than conducting a full independent evaluation.

What Regulatory Reliance Means

Regulatory reliance is the practice of one regulatory authority using the assessment or decision of another authority as the basis for its own review, without requiring a full independent evaluation. It is distinct from mutual recognition, where two authorities agree to treat each other's approvals as fully equivalent. Reliance is more common and more practical: the receiving authority retains discretion to accept, adapt, or reject the reference assessment, but it substantially reduces review time and resource burden for both the regulator and the applicant. Reliance pathways already operate across ASEAN — Singapore's HSA, for example, serves as a recognized reference authority for submissions in several ASEAN markets, and Thailand already has a formal reliance route for devices with HSA approval.

The Thailand-Malaysia Pilot

The Thailand FDA and Malaysia MDA launched the pilot as part of broader ASEAN Medical Device Directive harmonization efforts. If made permanent, the arrangement would allow devices holding a valid Malaysia MDA registration to apply for expedited TFDA review, with the MDA decision serving as the primary assessment reference. This reduces the TFDA review burden for qualifying devices and, from a manufacturer's perspective, can eliminate several months from the Thai registration timeline for devices already cleared in Malaysia.

What an ASEAN Cascade Could Look Like

The strategic value of a multi-market reliance cascade lies in the sequence. A manufacturer who achieves a strong initial registration in a recognized reference market — whether EU MDR, Singapore HSA, Malaysia MDA, or a combination — creates a foundation that unlocks faster pathways in downstream reliance-capable markets. Thailand, positioned as a regional hub with both HSA and potentially MDA reliance pathways, could become a regulatory gateway: achieve Thai FDA registration and use it as the basis for accelerated submissions in Vietnam, Indonesia, the Philippines, and other markets as ASEAN harmonization under the AMDD advances.

What the AMDD Framework Provides

The ASEAN Medical Device Directive (AMDD) creates the common classification and dossier framework that makes reliance technically feasible. All ASEAN member states have committed to implementing AMDD, and Thailand requires submission in the ASEAN Common Submission Dossier Template (CSDT) format for Class 2, 3, and 4 devices. A CSDT-structured dossier built for Thailand is already structured for use in reliance submissions across other AMDD-implementing markets. This is why DeeMED prepares Thai submissions with ASEAN reliance readiness in mind from the outset, rather than building a Thailand-only dossier that would require complete restructuring for each subsequent market.

What You Should Do Now

For manufacturers not yet registered in Thailand, the strategic value of Thai market entry has increased. Getting the Thai registration right — with a complete, CSDT-compliant dossier and AMDD-aligned technical file — positions you for faster follow-on submissions across reliance-capable ASEAN markets. For manufacturers already registered in Malaysia, the pilot reliance pathway is worth exploring with your Thai regulatory partner. DeeMED Consulting prepares TFDA submissions structured for both Thai regulatory compliance and ASEAN reliance readiness, building dossiers designed to travel across markets rather than requiring complete rebuilds for each country.